Gene Set: D4 : TTD - B-Octylglucoside
| Collection |
D4 : TTD |
| Chemical Name |
B-Octylglucoside ( From PubChem : B - O C T Y L G L U C O S I D E ) |
| FDA |
NPC |
WHO |
Indian |
Australia |
China |
Traditional
Herbal |
Clinical
Trail |
| Not | Not | Not | Not | Not | Not | Not | Not |
|
Molecular
Weight |
Hydrogen Bond
Donor Count |
Hydrogen Bond
Acceptor Count |
cLogP |
Lipinski Rule |
| 292.369 g/mol |
4 |
6 |
0.1634 |
True |
|
| Structure |
|
| InChI |
I n C h I = 1 S / C 1 4 H 2 8 O 6 / c 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 1 9 - 1 4 - 1 3 ( 1 8 ) 1 2 ( 1 7 ) 1 1 ( 1 6 ) 1 0 ( 9 - 1 5 ) 2 0 - 1 4 / h 1 0 - 1 8 H , 2 - 9 H 2 , 1 H 3 / t 1 0 - , 1 1 - , 1 2 + , 1 3 - , 1 4 - / m 1 / s 1 |
| InChIKey |
H E G S G K P Q L M E B J L - R K Q H Y H R C S A - N
|
| Links |
|
Gene
(16 /
16)
⊖ Less
|
| Source | Type | Unit | Value | Gene | PMID | Assay | Other | | TTD | Inhibitor | APOA2 | | | Research target | | TTD | Inhibitor | CYTB | | | Research target | | TTD | Inhibitor | DHODH | | | Successful target | | TTD | Inhibitor | LIPF | | | Successful target | | TTD | Inhibitor | LSS | | | Research target | | TTD | Inhibitor | MAPK14 | | | Clinical trial target | | TTD | Inhibitor | NOS2 | | | Successful target | | TTD | Inhibitor | NR3C1 | | | Successful target | | TTD | Inhibitor | NR3C2 | | | Successful target | | TTD | Inhibitor | PLA2G2A | | | Clinical trial target | | TTD | Inhibitor | PNLIP | | | Clinical trial target | | TTD | Inhibitor | PTGS1 | | | Successful target | | TTD | Inhibitor | PTGS2 | | | Successful target | | TTD | Inhibitor | PTPN1 | | | Clinical trial target | | TTD | Inhibitor | RHO | | | Research target | | TTD | Inhibitor | STS | | | Clinical trial target |
|
| Download gene sets |
gmt, text, Detailed text
|
Contact us
Tan Lab , Mail Stop 8117
12801 East 17th Avenue
Division of Medical Oncology , Department of Medicine
University of Colorado School of Medicine
Aurora, CO 80045, USA
* Best viewed in the latest version of Chrome (42+), Safari (8+), IE (11+) or Firefox (35+).
